Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 731

Whipple's Disease

Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644

New insights into the antiviral effects of chloroquine

Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570

Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 477

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century

Rolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 408

Impacts of COVID-19 pandemic on the wastewater pathway into surface water: A review

Bandala, E. R., Kruger, B. R., Cesarino, I., Leão, A. L., Wijesiri, B., & Goonetilleke, A. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145586 · Cited by 78

Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis

Kumar, N., Awasthi, A., Kumari, A., Sood, D., Jain, P., Singh, T., Sharma, N., Grover, A., & Chandra, R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1808072 · Cited by 79

Advancements in research and development to combat COVID-19 using nanotechnology

Chaudhary, V., Royal, A., Chavali, M. S., & Yadav, S. K. (2021) · Nanotechnology for Environmental Engineering · doi:10.1007/s41204-021-00102-7 · Cited by 80

Quantum mechanical simulation of Chloroquine drug interaction with C60 fullerene for treatment of COVID-19

Novir, S. B., & Aram, M. R. (2020) · Chemical Physics Letters · doi:10.1016/j.cplett.2020.137869 · Cited by 77

Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking

Mohapatra, S., Nath, P., Chatterjee, M., Das, N., Kalita, D., Roy, P., & Satapathi, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241543 · Cited by 77

Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic

Quinn, T. J., Burton, J. K., Carter, B., Cooper, N. J., Dwan, K. M., Field, R., Freeman, S. C., Geue, C., Hsieh, P.-H., McGill, K., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01920-x · Cited by 82

Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach

Azim, K. F., Ahmed, S. R., Banik, A., Khan, M. M. R., Deb, A., & Somana, S. R. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100367 · Cited by 75

Approaches towards fighting the COVID‑19 pandemic (Review)

Tsai, S., Lu, C., BAU, D.-T., Chiu, Y., Yen, Y., Hsu, Y., Fu, C., Kuo, S., Lo, Y., Chiu, H., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4794 · Cited by 77

Viral coinfections in COVID‐19

Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27102 · Cited by 82

SiO2-Ag Composite as a Highly Virucidal Material: A Roadmap that Rapidly Eliminates SARS-CoV-2

Assis, M., Simões, L. G. P., Tremiliosi, G. C., Coelho, D., Minozzi, D. T., Santos, R. I., Vilela, D. C. B., dos Santos, J. R., Ribeiro, L. K., Rosa, I. L. V., et al. (2021) · Nanomaterials · doi:10.3390/nano11030638 · Cited by 75

SAveRUNNER: an R-based tool for drug repurposing

Fiscon, G., & Paci, P. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04076-w · Cited by 78

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

Beura, S., & Chetti, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772111 · Cited by 73

COVID-19: etiology, clinical picture, treatment

MIu, S., Колобухина, Л. В., Burgasova, O., Сергеевна, К. И., & Vv, M. (2020) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-cec-1473 · Cited by 73

Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury

Lim, J., Park, S.-H., Jeon, Y., Cho, J., Jung, H., Choi, J., Kim, C., Lee, Y.-H., Seo, H., Lee, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061718 · Cited by 73

Epigallocatechin gallate and theaflavin gallate interaction in SARS‐CoV ‐2 spike‐protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study

Maiti, S., & Banerjee, A. (2020) · Drug Development Research · doi:10.1002/ddr.21730 · Cited by 72

Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?

Lee, S. H., Son, H., & Peck, K. R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105988 · Cited by 72

Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening

Nallusamy, S., Mannu, J., Ravikumar, C. N., Angamuthu, K., Nathan, B., Nachimuthu, K., Gnanam, R., Raveendran, M., Subbarayalu, M., & Neelakandan, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667704 · Cited by 75

Cardiac effects and toxicity of chloroquine: a short update

Mubagwa, K. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106057 · Cited by 75

A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection

Aktaş, G. (2020) · Experimental Biomedical Research · doi:10.30714/j-ebr.2020463629 · Cited by 72

Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID ‐19

Liu, J., Arockiaraj, M., Arulperumjothi, M., & Prabhu, S. (2021) · International Journal of Quantum Chemistry · doi:10.1002/qua.26617 · Cited by 70

A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions

Neerukonda, S. N., & Katneni, U. (2020) · Pathogens · doi:10.3390/pathogens9060426 · Cited by 70

Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world

Million, M., Gautret, P., Colson, P., Roussel, Y., Dubourg, G., Chabrière, É., Honoré, S., Rolain, J., Fenollar, F., Fournier, P., et al. (2020) · New Microbes and New Infections · doi:10.1016/j.nmni.2020.100709 · Cited by 67

Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus

Omolo, C. A., Soni, N., Fasiku, V. O., Mackraj, I., & Govender, T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173348 · Cited by 69

Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase

DiNicolantonio, J. J., & McCarty, M. F. (2020) · Open Heart · doi:10.1136/openhrt-2020-001337 · Cited by 68

Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study

Sen, D., Debnath, P., Debnath, B., Bhaumik, S., & Debnath, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1819883 · Cited by 67

Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review

Saghir, S. A. M., Al-Gabri, N. A., Alagawany, M. M., Attia, Y. A., Alyileili, S. R., Elnesr, S. S., Shafi, M. E., Alshargi, O., Al-balagi, N., Al-wajeeh, A. S., et al. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s301817 · Cited by 65

Pandemics and Traditional Plant-Based Remedies. A Historical-Botanical Review in the Era of COVID19

Garcia, S. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.571042 · Cited by 71

Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19

Rahman, M. T. (2020) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2020.100382 · Cited by 65

A perspective on yoga as a preventive strategy for coronavirus disease 2019

Majumdar, V., Nagarathna, R., & Nagendra, H. (2020) · International Journal of Yoga · doi:10.4103/ijoy.ijoy_22_20 · Cited by 64

A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin

Hellwig, M. D., & Maia, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106248 · Cited by 62

Therapeutic opportunities of edible antiviral plants for COVID-19

Patel, B. M., Sharma, S., Nair, N., Majeed, J., Goyal, R. K., & Dhobi, M. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04084-7 · Cited by 65

Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review

Plasencia-García, B. O., Rodríguez-Menéndez, G., Rico-Rangel, M. I., Rubio-García, A., Torelló-Iserte, J., & Crespo‐Facorro, B. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05716-4 · Cited by 61

Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal–Organic Framework Materials to Prevent the Onset of Heart Defects—In Vivo and In Vitro

Jodłowski, P. J., Kurowski, G., Kuterasiński, Ł., Sitarz, M., Jeleń, P., Jaśkowska, J., Kołodziej, A., Pajdak, A., Majka, Z., & Boguszewska‐Czubara, A. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c21508 · Cited by 61

Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

Oñate, J., Millan, W., Mendoza, L. A., Sánchez, C. G., Fernández-Suarez, H., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-00358-y · Cited by 60

Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options

Holzhauser, L., Lourenço, L. M., Sarswat, N., Kim, G. H., Chung, B., & Nguyen, A. B. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15982 · Cited by 60

Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19

Bocci, G., Bradfute, S. B., Ye, C., Garcia, M. J., Parvathareddy, J., Reichard, W., Surendranathan, S., Bansal, S., Bologa, C., Perkins, D. J., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00131 · Cited by 59

Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene

Akula, S. M., Bolin, P., & Cook, P. (2021) · RNA Biology · doi:10.1080/15476286.2021.2010959 · Cited by 61

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine

Sarayani, A., Cicali, B., Henriksen, C. H., & Brown, J. D. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.016 · Cited by 58

Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery

Lazaridis, C., Vlachogiannis, N. I., Bakogiannis, C., Spyridopoulos, I., Stamatelopoulos, K. S., Kanakakis, I., Vassilikos, V. P., & Stellos, K. (2020) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2020.05.004 · Cited by 60

Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development

Banerjee, A., Santra, D., & Maiti, S. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02435-4 · Cited by 58

Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19)

Tizaoui, K., Zidi, I., Lee, K. H., Ghayda, R. A., Hong, S. H., Li, H., Smith, L., Koyanagi, A., Jacob, L., Kronbichler, A., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.48812 · Cited by 57

Inhibitory activity of quercetin, its metabolite, and standard antiviral drugs towards enzymes essential for SARS-CoV-2: the role of acid–base equilibria

Milanović, Ž., Antonijević, M. R., Amić, A., Avdović, E., Dimić, D., Milenković, D., & Marković, Z. (2021) · RSC Advances · doi:10.1039/d0ra09632f · Cited by 58

First principle simulation of coated hydroxychloroquine on Ag, Au and Pt nanoparticles

Morad, R., Akbari, M., Rezaee, P., Koochaki, A., Mâaza, M., & Jamshidi, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-81617-6 · Cited by 61

Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review

Favilli, A., Gentili, M. M., Raspa, F., Giardina, I., Parazzini, F., Vitagliano, A., Borisova, A. V., & Gerli, S. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1774875 · Cited by 57

Advances in the possible treatment of COVID-19: A review.

Chibber, P., Haq, S. A., Ahmed, I., Andrabi, N. I., & Singh, G. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173372 · Cited by 56

Prediction studies of the epidemic peak of coronavirus disease in Brazil via new generalised Caputo type fractional derivatives

Kumar, P., Ertürk, V. S., Abboubakar, H., & Nisar, K. S. (2021) · Alexandria Engineering Journal · doi:10.1016/j.aej.2021.01.032 · Cited by 56

Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine

Bakadia, B. M., He, F., Souho, T., Lamboni, L., Ullah, M. W., Boni, B. O. O., Ahmed, A. A. Q., Mukole, B. M., & Yang, G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111008 · Cited by 56

Environmental and human health risk assessment of mixture of Covid-19 treating pharmaceutical drugs in environmental waters

Kumari, M., & Kumar, A. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.152485 · Cited by 55

SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners

Biondi‐Zoccai, G., Landoni, G., Carnevale, R., Cavarretta, E., Sciarretta, S., & Frati, G. (2020) · Minerva Cardioangiologica · doi:10.23736/s0026-4725.20.05250-0 · Cited by 54

Studies on viral pneumonia related to novel coronavirus SARS‐CoV‐2, SARS‐CoV, and MERS‐CoV: a literature review

Guo, L., Yuguang, W., Jian, L., Huaiping, Y., Xue, H., Jianwei, H., Jiaju, M., Lu, Y., Chen, M., & Jiao, Y. (2020) · Apmis · doi:10.1111/apm.13047 · Cited by 54

Issues for the management of people with diabetes and COVID-19 in ICU

Ceriello, A., Standl, E., Catrinoiu, D., Itzhak, B., Lalic, N. M., Rahelić, D., Schnell, O., Škrha, J., & Valensi, P. E. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01089-2 · Cited by 54

Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin

Derendorf, H. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106007 · Cited by 54

Three months of COVID ‐19: A systematic review and meta‐analysis

Rafiq, D., Batool, A., & Bazaz, M. A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2113 · Cited by 53

COVID-19 and immune checkpoint inhibitors: initial considerations

Sullivan, R. J., Johnson, D. B., Rini, B. I., Neilan, T. G., Lovly, C. M., Moslehi, J. J., & Reynolds, K. L. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000933 · Cited by 53

Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2

Colson, P., Lagier, J., Baudoin, J., Khalil, J. Y. B., Scola, B. L., & Raoult, D. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03869-w · Cited by 53

Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience

Pereda, R., Gonzalez, D. C., Rivero, H. B., Rivero, J. C., Pérez, A., López, L. D. R., Mezquia, N., Venegas, R., Betancourt, J. R., & Domínguez, R. E. (2020) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0124 · Cited by 52

A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)

Rameshrad, M., Ghafoori, M., Mohammadpour, A. H., Nayeri, M. J. D., & Hosseinzadeh, H. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01901-6 · Cited by 51

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening

Dehelean, C. A., Lăzureanu, V. E., Coricovac, D. E., Mioc, M., Oancea, R., Marcovici, I., Pînzaru, I., Şoica, C., Tsatsakis, A. M., & Cretu, O. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072084 · Cited by 53

A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19Preprint

Belhadi, D., Peiffer‐Smadja, N., Lescure, F.-X., Yazdanpanah, Y., Mentré, F., & Laouenan, C. (2020) · medRxiv · doi:10.1101/2020.03.18.20038190 · Cited by 51

Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection

Klimke, A., Hefner, G., Will, B., & Voss, U. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109783 · Cited by 50

A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery

Ulhas, R. S., & Praveen, N. (2021) · VirusDisease · doi:10.1007/s13337-021-00683-6 · Cited by 50

The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targets

Sargazi, S., Sheervalilou, R., Rokni, M., Shirvaliloo, M., Shahraki, O., & Rezaei, N. (2021) · Cell Biology International · doi:10.1002/cbin.11609 · Cited by 51

Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach

Lv, Y., Wang, S., Liang, P., Wang, Y., Zhang, X., Jia, Q., Fu, J., Han, S., & He, L. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03233-7 · Cited by 50

Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community

Luo, Z., Ang, M. J. Y., Chan, S. Y., Yi, Z., Goh, Y. Y., Yan, S., Tao, J., Liu, K., Li, X., Zhang, H., et al. (2020) · Research · doi:10.34133/2020/6925296 · Cited by 51

Janus sword actions of chloroquine and hydroxychloroquine against COVID-19

Chen, X., & Geiger, J. D. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109706 · Cited by 50

COVID‐19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement

Wang, C. Y., Rademaker, M., Baker, C., & Foley, P. A. (2020) · Australasian Journal of Dermatology · doi:10.1111/ajd.13313 · Cited by 48

The prophylaxis and treatment potential of supplements for COVID-19

Sahebnasagh, A., Saghafi, F., Avan, R., Khoshi, A., Khataminia, M., Safdari, M., Habtemariam, S., Ghaleno, H. R., & Nabavi, S. M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173530 · Cited by 48

SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression

Cajamarca-Barón, J., Guavita-Navarro, D., Buitrago-Bohórquez, J., Gallego-Cardona, L., Navas, Á., Cubides, H. H., Arredondo, A. M., Escobar, A., & Rojas‐Villarraga, A. (2020) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2020.08.001 · Cited by 47

SARS-CoV-2 M pro inhibitors: identification of anti-SARS-CoV-2 M pro compounds from FDA approved drugs

Bharadwaj, S., Azhar, E. I., Kamal, M. A., Bajrai, L. H., Dubey, A., Jha, K., Yadava, U., Kang, S. G., & Dwivedi, V. D. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1842807 · Cited by 48

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study

Lane, J. C. E., Weaver, J. C., Kostka, K., Duarte‐Salles, T., Abrahão, M. T. F., Alghoul, H., Alser, O. H., Alshammari, T. M., Areia, C. M., Biedermann, P., et al. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa771 · Cited by 48

Can pharmaceutical drugs used to treat Covid-19 infection leads to human health risk? A hypothetical study to identify potential risk

Kumari, M., & Kumar, A. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146303 · Cited by 49

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021

Alam, S., Kamal, T. B., Sarker, M. M. R., Zhou, J., Rahman, S. M. A., & Mohamed, I. N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.659577 · Cited by 53

Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Beeraka, N. M., Sadhu, S. P., Madhunapantula, S. V., Pragada, R. R., Svistunov, A. А., Nikolenko, V. N., Михалева, Л. М., & Aliev, G. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.552925 · Cited by 47

COVID-19 Outbreak and Perspective in Morocco

Addi, R. A., Benksim, A., Amine, M., & Cherkaoui, M. (2020) · Electronic Journal of General Medicine · doi:10.29333/ejgm/7857 · Cited by 48

Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials

Deb, B., Shah, H., & Goel, S. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00053-2 · Cited by 51

COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact

Sood, S., Aggarwal, V., Aggarwal, D., Upadhyay, S. K., Sak, K., Tuli, H. S., Kumar, M., Kumar, J., & Talwar, S. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00229-2 · Cited by 48

Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?

Chang, X., Ismail, N. I., Rahman, A., Xu, D., Chan, R. W. Y., Ong, S., & Ong, S. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0126 · Cited by 53

Identifying side effects of commonly used drugs in the treatment of Covid 19

Aygün, İ., Kaya, M., & Alhajj, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-78697-1 · Cited by 46

Removal of Hydroxychloroquine Using Engineered Biochar from Algal Biodiesel Industry Waste: Characterization and Design of Experiment (DoE)

Gümüş, D., & Gümüş, F. (2021) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-021-06235-w · Cited by 48

Quantifying the Risk of Indoor Drainage System in Multi-unit Apartment Building as a Transmission Route of SARS-CoV-2

Shi, K.-W., Huang, Y.-H., Quon, H., Ouyang, Z., Wang, C., & Jiang, S. C. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143056 · Cited by 50

In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective

Rahman, M. M., Islam, M. R., Akash, S., Mim, S. A., Rahaman, M. S., Emran, T. B., Akkol, E. K., Sharma, R., Alhumaydhi, F. A., Sweilam, S. H., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.929430 · Cited by 49

The fourth industrial revolution and the coronavirus: a new era catalyzed by a virus

Neto, R. D. C. S., Maia, J. S., Neiva, S. D. S., Scalia, M. D., & Guerra, J. B. S. O. D. A. (2020) · Research in Globalization · doi:10.1016/j.resglo.2020.100024 · Cited by 46

Literature-based review of the drugs used for the treatment of COVID-19

Venkatasubbaiah, M., Reddy, P. D., & Satyanarayana, S. V. (2020) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2020.05.013 · Cited by 45

A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections

Hoang, B. X., & Han, B. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110333 · Cited by 45

Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach

Fadaka, A. O., Aruleba, R. T., Sibuyi, N. R. S., Klein, A., Madiehe, A. M., & Meyer, M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1847197 · Cited by 48

Application of machine learning for the diagnosis of COVID-19

Podder, P., Bharati, S., Mondal, M. R. H., & Köse, U. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824536-1.00008-3 · Cited by 45

Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants

Badraoui, R., Saoudi, M., Hamadou, W. S., Elkahoui, S., Siddiqui, A. J., Alam, M. J., Jamal, A., Adnan, M., Suliemen, A. M. E., Alreshidi, M. M., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15020129 · Cited by 46

COVID-19 associated with AIDS-related disseminated histoplasmosis: a case report

Bertolini, M., Mutti, M. F., Barletta, J., Falak, A., Cuatz, D., Sisto, A. E., Ragusa, M. A., Claros, N. O. F., & Rolón, M. J. (2020) · International Journal of STD & AIDS · doi:10.1177/0956462420957518 · Cited by 44

Screening of Potent Inhibitors Against 2019 Novel Coronavirus (Covid-19) from Alliumsativum and Allium cepa: An In Silico Approach

(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac111.79817993 · Cited by 44

Renal Manifestations of Covid-19: Physiology and Pathophysiology

Armaly, Z., Kinaneh, S., & Skorecki, K. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061216 · Cited by 45

Benign COVID-19 in an immunocompromised cancer patient – the case of a married couple

Spezzani, V., Piunno, A., & Iselin, H.-U. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20246 · Cited by 43

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review

Mascolo, A., Scavone, C., Rafaniello, C., Ferrajolo, C., Racagni, G., Berrino, L., Paolisso, G., Rossi, F., & Capuano, A. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00143 · Cited by 42

The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis

Shamshirian, A., Hessami, A., Heydari, K., Alizadeh‐Navaei, R., Ebrahimzadeh, M. A., Yip, G. W. C., Ghasemian, R., Sedaghat, M., Baradaran, H., Yazdii, S. M., et al. (2020) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmed.sg.2020370 · Cited by 46

Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices

Ardura, M. I., Hartley, D., Dandoy, C. E., Lehmann, L., Jaglowski, S. M., & Auletta, J. J. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.04.018 · Cited by 44

Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening

Abdusalam, A. A. A., & Murugaiyah, V. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.603037 · Cited by 42

Current pharmacological treatments for SARS-COV-2: A narrative review

Nittari, G., Pallotta, G., Amenta, F., & Tayebati, S. K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173328 · Cited by 42

Antidepressant Drug Sertraline against Human Cancer Cells

Duarte, D., & Vale, N. (2022) · Biomolecules · doi:10.3390/biom12101513 · Cited by 42

A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19

Sharun, K., Tiwari, R., Yatoo, M. I., Natesan, S., Megawati, D., Singh, K. P., Michalak, I., & Dhama, K. (2022) · Narra J · doi:10.52225/narra.v2i3.92 · Cited by 42

Un nuevo coronavirus, una nueva enfermedad: COVID-19

Universidad de San Martín de Porres, F. D. M. H., Carrillo, C., Cruz, A. P., Universidad de San Martín de Porres, F. D. M. H., Ayala, E. V., Universidad de San Martín de Porres, F. D. M. H., Valencia, Y. E., Universidad de San Martín de Porres, F. D. M. H., de León, J., Universidad de San Martín de Porres, F. D. M. H., et al. (2020) · Horizonte Médico (Lima) · doi:10.24265/horizmed.2020.v20n2.11 · Cited by 54

Can we use hydroxychloroquine to treat COVID-19 now?

Chen, J., Liu, D., Yin, L., Zhang, L., & Lu, H. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106173 · Cited by 1

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine

Sahraei, Z., Shabani, M., Shokouhi, S., & Saffaei, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105945 · Cited by 234

Chloroquine and hydroxychloroquine as potential therapies against COVID-19

Yewange, S., Deshpande, R. R., Waghmare, N., Vidyasagar, G., Bavage, S. B., & Bavage, N. B. (2020) · Cited by 1

Chloroquine as a prophylactic agent against COVID-19?

Gendrot, M., Javelle, É., Clerc, A., Savini, H., & Pradines, B. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105980 · Cited by 44

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471